摘要
Nephrolithiasis is a common source of morbidity with a lifetime prevalence of 5%-10%. Despite technical advances in the treatment ofnephrolithiasis, the prevalence of stone disease appears to be increasing. Raised serum and/or urinary uric acid are a well-established risk factor for calculogenesis.
Nephrolithiasis is a common source of morbidity with a lifetime prevalence of 5%-10%. Despite technical advances in the treatment ofnephrolithiasis, the prevalence of stone disease appears to be increasing. Raised serum and/or urinary uric acid are a well-established risk factor for calculogenesis.
